Literature DB >> 11755339

N-acyl-L-phenylalanine derivatives as potent VLA-4 antagonists that mimic a cyclic peptide conformation.

Li Chen1, Jefferson Tilley, Richard V Trilles, Weiya Yun, David Fry, Charles Cook, Karen Rowan, Virginia Schwinge, Robert Campbell.   

Abstract

A series of N-benzylpyroglutamyl-L-phenylalanine derivatives bearing carbamoyl substituents in the 3- or 4-positions was prepared and assayed for inhibition of the interaction between VCAM and VLA-4. Potent inhibition was observed in a number of analogues with substitution in the 4-position favored over the 3-position. A crystal structure of the key intermediate 25 indicates that it accesses a low energy conformation which closely matches key pharmacophores of a structurally characterized cyclic peptide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755339     DOI: 10.1016/s0960-894x(01)00711-9

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  A general method for discovering inhibitors of protein-DNA interactions using photonic crystal biosensors.

Authors:  Leo L Chan; Maria Pineda; James T Heeres; Paul J Hergenrother; Brian T Cunningham
Journal:  ACS Chem Biol       Date:  2008-07-18       Impact factor: 5.100

2.  NMR structure of a complex between MDM2 and a small molecule inhibitor.

Authors:  David C Fry; S Donald Emerson; Stefan Palme; Binh T Vu; Chao-Min Liu; Frank Podlaski
Journal:  J Biomol NMR       Date:  2004-10       Impact factor: 2.835

Review 3.  Role of integrin alpha4 in drug resistance of leukemia.

Authors:  Stephanie Shishido; Halvard Bönig; Yong-Mi Kim
Journal:  Front Oncol       Date:  2014-05-23       Impact factor: 6.244

4.  Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors.

Authors:  Georgi Stavrakov; Irena Philipova; Atanas Lukarski; Mariyana Atanasova; Dimitrina Zheleva; Zvetanka D Zhivkova; Stefan Ivanov; Teodora Atanasova; Spiro Konstantinov; Irini Doytchinova
Journal:  Molecules       Date:  2020-07-23       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.